Skip to main content
Clinical Trials/DRKS00023243
DRKS00023243
Completed
N/A

Resistance training as prehabilitation exercise in Mamma-CA - PräMaCa

niklinik Köln, Centrum für integrierte Onkologie (CIO)0 sites66 target enrollmentDecember 17, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Post-OP complicationsHealth related quality of life, FatiqueAnxiety and depression,lymphedemapolyneuropathie
Sponsor
niklinik Köln, Centrum für integrierte Onkologie (CIO)
Enrollment
66
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2020
End Date
May 8, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niklinik Köln, Centrum für integrierte Onkologie (CIO)

Eligibility Criteria

Inclusion Criteria

  • diagnosed breast cancer
  • at least 12 weeks prior to surgical therapy (breast\-conserving therapy (BET) or radical mastectomy with axillary dissection)
  • neo\-adjuvant chemotherapy or neo\-adjuvant radio\-chemotherapy
  • Written and valid declaration of consent from the patient
  • Age\> \= 18 years

Exclusion Criteria

  • Neo\-adjuvant radiotherapy alone
  • Second malignancies
  • WHO / ECOG performance status\> 1
  • Life expectancy \<5 months
  • ductal carcinoma
  • metastases
  • All illness situations that do not allow hypertrophy training, in particular:
  • o Clinically manifest heart failure (NYHA III\-IV)
  • o Partial or global respiratory failure
  • o Permanent thrombocytopenia \<10,000 / µl, e.g. refractory autoimmune thrombocytopenias.

Outcomes

Primary Outcomes

Not specified

Similar Trials